Re: [討論] 高端疫苗又上國際知名醫學期刊了！

看板HatePolitics作者nicolaschen2 (ii)時間2年前 (2021/11/07 20:17)推噓-2(2推 4噓 5→)

留言11則, 7人參與討論串2/2 (看更多)

塔綠班真的不愧是塔綠班，人家高端自己都講了，我這篇論文沒有保護力的相關資料喔！但是塔綠班還是可以很爽高潮，笑死。高端也講了，他這個是在中和抗體最高的時候量的資料，但是中和抗體變少之後，就要看 t細胞會不會起到對付變種的作用，但他們自己也不清楚，可是塔綠班已經覺得高端是神藥，在那邊爽歪歪，北七！ A limitation of our study is that the sera were taken 4 weeks after the second shot of MVC-COV1901 when immunity has peaked and only just started to wane. T herefore, we could not evaluate the impact of waning immunity on the neutraliz ing capacity against the variants. The study cannot evaluate the role of T-cel l responses elicited by the vaccine as it was reported that the T-cell respons es to immunization may confer heterotypic coverage and are less affected by Vo Cs [31]. COVID-19 vaccines in phase 3 clinical trials in South Africa when the Beta var iant became predominant showed considerably high protection against severe cli nical endpoints, while overall efficacy is lower than at sites outside of Sout h Africa [32]. Since there are no correlates options of protection being published for emergi ng variants, it warrants further study on how the reduced neutralizing titers will translate to clinical endpoints. We are currently conducting a randomized , double-blind, placebo-controlled phase 2 study for safety and immunogenicity of MVC-COV1901 with >3800 subjects (NCT04695652). The samples from the phase 2 trial would allow us to further investigate the effects of variants on neutr alizing titers by using a larger set of samples and newer variants. -- ※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 27.52.154.135 (臺灣) ※ 文章網址: https://www.ptt.cc/bbs/HatePolitics/M.1636287475.A.6FA.html

推

karevin07

11/07 20:18, 2年前 , 1^F

11/07 20:18, 1^F

→

angellll

11/07 20:19, 2年前 , 2^F

11/07 20:19, 2^F

噓

Pietro

11/07 20:23, 2年前 , 3^F

11/07 20:23, 3^F